ArticleArchives of toxicology2025
LINE-1 DNA methylation mediates smoking-related risk in site-specific urothelial carcinoma: a Taiwan case-control study.
Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancements and Clinical Applications Prospects of Epigenetic Biomarkers in Liquid Biopsy for Oral Squamous Cell Carcinoma.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
While environmental and lifestyle factors contribute to urothelial carcinoma (UC) development, their differential effects on bladder cancer (UB) versus upper tract urothelial carcinoma (UTUC) and the underlying epigenetic mechanisms remain unclear. This study investigated location-specific risk factors and the mediating role of LINE-1 DNA methylation in UC carcinogenesis. A hospital-based case-control study was conducted, comprising 478 UC cases (266 UB, 204 UTUC) and 569 controls. The risk factors, including smoking, Chinese herbal medicine use, comorbidities, and blood levels of arsenic, cadmium, and lead, were assessed through questionnaires and blood sample analysis. LINE-1 DNA methylation levels were measured by pyrosequencing. LASSO regression for variable selection and logistic regression for risk assessment. Mediation analysis was performed to evaluate the role of LINE-1 DNA methylation in the relationship between environmental exposures and UC risk. UB risk was associated with male sex, smoking, chronic kidney disease (CKD), elevated blood arsenic, and diabetes (all p < 0.0001), while UTUC risk was primarily linked to female sex (p = 0.0004) and CKD (p < 0.0001). LINE-1 hypermethylation was associated with both UB and UTUC risk (p < 0.0001). Notably, LINE-1 methylation significantly mediated the relationship between smoking and UC risk, particularly in males, while no significant mediation was observed for other exposures. This study demonstrates distinct risk profiles for UB and UTUC, and identifies LINE-1 methylation as a key mediator in smoking-related UC risk, especially in men. These findings suggest the need for location-specific prevention strategies and highlight the importance of epigenetic mechanisms in UC development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.